Search Results

Filter
  • 1-10 of  1,178 results for ""Adenine Nucleotides""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dual anti-HIV mechanism of clofarabine.

  • Authors : Daly MB; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, 1760 Haygood Dr., Atlanta, GA, 30322, USA.; Roth ME

Subjects: Adenine Nucleotides/Adenine Nucleotides/Adenine Nucleotides/*pharmacology ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology ; Antimetabolites/Antimetabolites/Antimetabolites/*pharmacology

  • Source: Retrovirology [Retrovirology] 2016 Mar 24; Vol. 13, pp. 20. Date of Electronic Publication: 2016 Mar 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101216893 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-4690

Record details

×
Academic Journal

Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).

  • Authors : Dimitrova DI; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.; Reichenbach NL

Subjects: Lipopolysaccharide Receptors*; Adenine Nucleotides/Adenine Nucleotides/Adenine Nucleotides/*pharmacology ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology

  • Source: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2007 Jan; Vol. 23 (1), pp. 123-34.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8709376 Publication Model: Print Cited Medium: Print ISSN: 0889-2229

Record details

×
Academic Journal

Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat.

  • Authors : Zhou L; Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ 86011-5698, USA.; Thakur CS

Subjects: Drug Delivery Systems*; Adenine Nucleotides/Adenine Nucleotides/Adenine Nucleotides/*chemistry ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*chemical synthesis

  • Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2006 Dec 01; Vol. 14 (23), pp. 7862-74.Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print Cited Medium: Print ISSN: 0968-0896 (Print)

Record details

×
Academic Journal

Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?

  • Authors : Hill A; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives ; Alanine*/Alanine*/Alanine*/therapeutic use

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 15; Vol. 79 (4), pp. 1006-1009.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protocol of a drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV.

  • Authors : Lacombe-Duncan A; Women's College Hospital, Toronto, Ontario, Canada.; School of Social Work, University of Michigan, Ann Arbor, Michigan, USA.

Subjects: Drug Interactions* ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Emtricitabine*/Emtricitabine*/Emtricitabine*/pharmacokinetics

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2349-2359. Date of Electronic Publication: 2024 Jul 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

No observed bidirectional effect between tenofovir diphosphate concentrations and gender-affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis.

  • Authors : Patel N; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.; Morris S

Subjects: Transgender Persons* ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2360-2365. Date of Electronic Publication: 2024 Apr 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.

  • Authors : Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Kelly CW

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/pharmacokinetics ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. 696-705.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial.

  • Authors : Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Spinner CD

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control

  • Source: The lancet. HIV [Lancet HIV] 2024 Aug; Vol. 11 (8), pp. e508-e521. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/adverse effects ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: AIDS (London, England) [AIDS] 2024 Jul 15; Vol. 38 (9), pp. 1442-1445. Date of Electronic Publication: 2024 Jun 27.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques.

  • Authors : Makarova N; Laboratory Branch, Division of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.; Singletary T

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives ; Quinolones*/Quinolones*/Quinolones*/administration & dosage

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1791-1795.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,178 results for ""Adenine Nucleotides""